Açık Akademik Arşiv Sistemi

Review of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem-Vaborbactam and Imipenem-Relebactam in Carbapenemase Producing Klebsiella pneumoniae Isolates

Show simple item record

dc.contributor.authors Aydemir, O; Köroglu, M; Sahin, EÖ; Vural, S
dc.date.accessioned 2024-02-23T11:45:27Z
dc.date.available 2024-02-23T11:45:27Z
dc.date.issued 2023
dc.identifier.issn 2147-673X
dc.identifier.uri http://dx.doi.org/10.4274/mjima.galenos.2023.2023.17
dc.identifier.uri https://hdl.handle.net/20.500.12619/102319
dc.description Bu yayın 06.11.1981 tarihli ve 17506 sayılı Resmî Gazete’de yayımlanan 2547 sayılı Yükseköğretim Kanunu’nun 4/c, 12/c, 42/c ve 42/d maddelerine dayalı 12/12/2019 tarih, 543 sayılı ve 05 numaralı Üniversite Senato Kararı ile hazırlanan Sakarya Üniversitesi Açık Bilim ve Açık Akademik Arşiv Yönergesi gereğince açık akademik arşiv sistemine açık erişim olarak yüklenmiştir.
dc.description.abstract Introduction: To investigate the in vitro efficacy of three new antimicrobial agents [ceftazidime-avibactam (CAZ-AVI), meropenem-vaborbactam (V/R) and imipenem/cilastatin-relebactam] in isolates of carbapenemase-producing Klebsiella pneumoniae (CPKP). Materials and Methods: Thirty CPKP strains were included in our study. The strains were identified at the species level using Vitek MS, and antimicrobial susceptibility tests were performed using the Vitek 2 automated system. Carbapenemase production in all strains was confirmed by the combination disc test. The blaKPC, blaNDM-1, blaOXA-48 and blaVIM genes were identified using the Gene-Xpert (R) System Carba R (R) kit (Cepheid, Sunnyvale, USA). Imipenem/relebactam (I/R), V/R, CAZ-AVI susceptibilities were investigated by using gradient strip test. Antimicrobial susceptibility results were interpreted according to the recommendations the EUCAST. Minimal inhibitory concentration (MIC) cut-off values were as follows: For IR, MIC >2 susceptible, MIC =2 resistant; for M/V, MIC >8 resistant, MIC <8 susceptible; and for CAZ-AVI, MIC >8 resistant, MIC <8 susceptible. Results: All of the strains included in the study were resistant to all antibiotics except colistin. BlaOXA-48 was detected in 76.6% of the isolates; NDM-1 in 16.6%; NDM-1 and OXA-48 in 3.3%, and KPC in 3.3%. Twenty (66.6%) strains were susceptible to I/R, 18 (60%) were susceptible to M/V, and 21 (70%) were susceptible to CAZ/AVI. While 90% of the I/R susceptible isolates carried OXA-48, the other two isolates had KPC and NDM-1. Of the I/R resistant isolates 50% carried OXA-48, 40% NDM-1, and 1 NDM-1 and OXA-48. Of the M/V susceptible isolates, 88.8% carried OXA-48, other isolates NDM-1 and KPC. Of the resistant isolates, 58.3% carried OXA-48, 33.3% NDM-1, and 8.1% NDM-1/OXA-48. Of the isolates susceptible to CAZ/AVI 95.2% carried OXA-48 and 4.7% NDM-1. Of the I/R resistant isolates with a MIC >8, two carried the blaOXA-48 gene and two carried the NDM-1 gene. NDM-1 gene was present in four of the M/V resistant isolates with MIC >8. It was determined that 56.6% of the strains were susceptible to all antimicrobial agents and 23.3% were found to be resistant to all agents. While 4 (57.1%) of these strains carried NDM gene, Conclusion: The most common gene detected in CPKP strains inour center was found to be OXA-48 gene. These results were similar to the data for Turkey. This situation should be considered during the clinical use of I/R and M/V, which are known to have low susceptibility in OXA-48 carrying strains in our country. Our study showed that CAZ/AVI susceptibility was higher in KPC strains.
dc.language English
dc.language.iso eng
dc.publisher GALENOS PUBL HOUSE
dc.relation.isversionof 10.4274/mjima.galenos.2023.2023.17
dc.subject Ceftazidime-avibactam
dc.subject meropenem-vaborbactam
dc.subject imipenem-relebactam
dc.subject OXA-48
dc.title Review of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem-Vaborbactam and Imipenem-Relebactam in Carbapenemase Producing Klebsiella pneumoniae Isolates
dc.type Article
dc.type Proceedings Paper
dc.identifier.volume 12
dc.relation.journal MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS
dc.identifier.doi 10.4274/mjima.galenos.2023.2023.17
dc.contributor.author Aydemir, Ozlem
dc.contributor.author Koroglu, Mehmet
dc.contributor.author Sahin, Elif Ozozen
dc.contributor.author Vural, Sevinc
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rights.openaccessdesignations gold


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record